RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Portage Biotech Stock

Portage Biotech Net Income 2024

Portage Biotech Net Income

-75.34 M USD

Ticker

PRTG

ISIN

VGG7185A1286

WKN

A2P6BP

In 2024, Portage Biotech's profit amounted to -75.34 M USD, a -27.98% increase from the -104.61 M USD profit recorded in the previous year.

The Portage Biotech Net Income history

YEARNET INCOME (undefined USD)
2029e2.51
2028e-1.16
2027e-1.59
2026e-0.56
2025e-0.56
2024-75.34
2023-104.61
2022-16.87
2021-15.83
2020-5.33
2019-2.64
2018123.74
201716.3
2016-5.71
2015-3.12
2014-6.3
2013-1.47
2012-2.49
2011-3.67
2010-3.6
2009-0.61
2008-0.56
2007-0.16

Portage Biotech Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Portage Biotech, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Portage Biotech from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Portage Biotech’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Portage Biotech. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Portage Biotech’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Portage Biotech’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Portage Biotech’s growth potential.

Portage Biotech Revenue, EBIT and net profit per share

DatePortage Biotech RevenuePortage Biotech EBITPortage Biotech Net Income
2029e63.14 M undefined0 undefined2.51 M undefined
2028e2.55 M undefined-61.2 M undefined-1.16 M undefined
2027e0 undefined-49.98 M undefined-1.59 M undefined
2026e0 undefined-18.79 M undefined-556,919.93 undefined
2025e0 undefined-16.75 M undefined-556,919.93 undefined
20240 undefined-18.25 M undefined-75.34 M undefined
20230 undefined-16.57 M undefined-104.61 M undefined
20220 undefined-15.59 M undefined-16.87 M undefined
20210 undefined-12.44 M undefined-15.83 M undefined
20200 undefined-5.98 M undefined-5.33 M undefined
20190 undefined-2.76 M undefined-2.64 M undefined
20180 undefined-2.24 M undefined123.74 M undefined
20170 undefined-35.49 M undefined16.3 M undefined
20160 undefined-9.19 M undefined-5.71 M undefined
20150 undefined-4.32 M undefined-3.12 M undefined
20140 undefined-2.79 M undefined-6.3 M undefined
2013100,000 undefined-1.26 M undefined-1.47 M undefined
20120 undefined-1.62 M undefined-2.49 M undefined
20110 undefined-2.38 M undefined-3.67 M undefined
2010-780,000 undefined-3.18 M undefined-3.6 M undefined
200950,000 undefined-660,000 undefined-610,000 undefined
2008310,000 undefined-420,000 undefined-560,000 undefined
2007740,000 undefined-40,000 undefined-160,000 undefined

Portage Biotech stock margins

The Portage Biotech margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Portage Biotech. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Portage Biotech.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Portage Biotech's sales revenue. A higher gross margin percentage indicates that the Portage Biotech retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Portage Biotech's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Portage Biotech's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Portage Biotech's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Portage Biotech. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Portage Biotech's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Portage Biotech Margin History

Portage Biotech Gross marginPortage Biotech Profit marginPortage Biotech EBIT marginPortage Biotech Profit margin
2029e0 %0 %3.97 %
2028e0 %-2,400 %-45.36 %
2027e0 %0 %0 %
2026e0 %0 %0 %
2025e0 %0 %0 %
20240 %0 %0 %
20230 %0 %0 %
20220 %0 %0 %
20210 %0 %0 %
20200 %0 %0 %
20190 %0 %0 %
20180 %0 %0 %
20170 %0 %0 %
20160 %0 %0 %
20150 %0 %0 %
20140 %0 %0 %
20130 %-1,260 %-1,470 %
20120 %0 %0 %
20110 %0 %0 %
20100 %407.69 %461.54 %
20090 %-1,320 %-1,220 %
20080 %-135.48 %-180.65 %
20070 %-5.41 %-21.62 %

Portage Biotech Aktienanalyse

What does Portage Biotech do?

Portage Biotech Inc is an international biotechnology company based in Canada. The company was established in 2015 as a holding company and took control of the stock of Biohaven Pharmaceutical Holding Company. Portage Biotech operates in various locations, including Canada, the US, and Europe. The business model of Portage Biotech is based on identifying promising new technologies and creating companies that utilize these technologies. The company employs a strategic investment strategy, acquiring stakes in promising biotechnology companies and working closely with them to bring their products and therapies to market. Another strategy of Portage Biotech is the establishment of innovation centers in different countries. This involves bringing together highly skilled personnel and cutting-edge technologies under one roof to create innovative products and solutions that can be brought to the global market. The company also operates in several business areas, including medical research and development. In this field, Portage Biotech works on developing new therapies, particularly in the field of cancer research. Additionally, the company has a division for medical diagnostics, where innovative testing procedures are developed to contribute to early disease detection. Another important business area for Portage Biotech is the manufacturing of biopharmaceuticals, which are drugs based on biological agents. The company collaborates closely with other biotechnology companies to bring innovative products to the market. Portage Biotech has already successfully implemented a number of promising projects, including the development of therapies for cancer, Alzheimer's, and Parkinson's. The company also has promising biosimilars and biosuperior products in the pipeline that could revolutionize the market. To successfully execute these projects, Portage Biotech has assembled an impressive leadership team. The company has an experienced team of scientists, managers, and professionals who are dedicated to finding the best solutions for the challenges of the biotechnology industry. Overall, Portage Biotech is an innovative company that focuses on the discovery and promotion of promising new technologies. The company has already achieved an impressive track record and has the potential to play a revolutionary role in the field of biotechnology. Portage Biotech ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Net Income Details

Understanding Portage Biotech's Profit Margins

The profit margins of Portage Biotech represent the net income earned after deducting all operational expenses, costs, and taxes from the revenue. This figure is a clear indicator of Portage Biotech's financial health, operational efficiency, and profitability. Higher profit margins signify better cost management and income generation capabilities.

Year-to-Year Comparison

Evaluating Portage Biotech's profit on a yearly basis can offer significant insights into its financial growth, stability, and trends. A consistent increase in profit suggests improved operational efficiency, cost management, or increased revenue, while a decrease may indicate rising costs, declining sales, or operational challenges.

Impact on Investments

Portage Biotech's profit figures are critical for investors who are aiming to understand the company's financial standing and future growth prospects. Increased profits often lead to higher stock valuations, boosting investor confidence and attracting more investments.

Interpreting Profit Fluctuations

When Portage Biotech’s profit increases, it often indicates enhanced operational efficiency or increased sales. In contrast, a decline in profit can signal operational inefficiencies, increased costs, or competitive pressures, necessitating strategic interventions to boost profitability.

Frequently Asked Questions about Portage Biotech stock

How much profit has Portage Biotech made this year?

Portage Biotech has made -75.34 M USD this year.

How has the profit developed compared to last year?

The profit has increased by -27.98% compared to last year fallen

What impact do the earnings have on the shareholders?

An increase in earnings is usually seen as a positive indicator for shareholders as it means that the company is generating profits.

How does Portage Biotech publish its earnings?

Portage Biotech publishes its earnings in the form of quarterly or annual reports.

Which financial indicators are included in the quarterly or annual reports?

The quarterly or annual reports contain information about sales and profit, cash flow, balance sheet, and other fundamentals.

Why is it important for investors to know the earnings of Portage Biotech?

The profits of Portage Biotech are an important indicator of the financial health of the company and can help investors decide whether they want to invest in the company or not.

How can one learn more about the earnings of Portage Biotech?

You can learn more about the earnings of Portage Biotech by reviewing the quarterly or annual reports or following the company presentations.

How much dividend does Portage Biotech pay?

Over the past 12 months, Portage Biotech paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Portage Biotech is expected to pay a dividend of 0 USD.

What is the dividend yield of Portage Biotech?

The current dividend yield of Portage Biotech is .

When does Portage Biotech pay dividends?

Portage Biotech pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Portage Biotech?

Portage Biotech paid dividends every year for the past 0 years.

What is the dividend of Portage Biotech?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Portage Biotech located?

Portage Biotech is assigned to the 'Health' sector.

Wann musste ich die Aktien von Portage Biotech kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Portage Biotech from 10/2/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 10/2/2024.

When did Portage Biotech pay the last dividend?

The last dividend was paid out on 10/2/2024.

What was the dividend of Portage Biotech in the year 2023?

In the year 2023, Portage Biotech distributed 0 USD as dividends.

In which currency does Portage Biotech pay out the dividend?

The dividends of Portage Biotech are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Portage Biotech

Our stock analysis for Portage Biotech Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Portage Biotech Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.